Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Da-Gong Wang
Observed names:
Da-gong Wang,
Dagong Wang
Observed institutions:
Queen's University Belfast,
Curis (United States)
OpenAlex ID:
A5020572091
Prevalent Overexpression of Prolyl Isomerase Pin1 in Human Cancers
2004
·
Lere Bao
, Amy Kimzey
, et al.
·
American Journal Of Pathology
·
386
PDF
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2012
·
Changgeng Qian
, Cheng-Jung Lai
, et al.
·
Clinical Cancer Research
·
249
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2010
·
Cheng-Jung Lai
, Rudi Bao
, et al.
·
Cancer Research
·
217
PDF
The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
2003
·
Gustavo Ayala
, Dagong Wang
, et al.
·
PubMed
·
216
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
2009
·
Rudi Bao
, Cheng-Jung Lai
, et al.
·
Clinical Cancer Research
·
116
PDF
Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer
2009
·
Rudi Bao
, Cheng-Jung Lai
, et al.
·
Molecular Cancer Therapeutics
·
60
Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53
1998
·
Da-Gong Wang
, Colin F. Johnston
, et al.
·
The Journal of Pathology
·
39
Oncogene expression in carotid body tumors
1996
·
Da-Gong Wang
, Aaros A. B. Barros D'Sa
, et al.
·
Cancer
·
22
Abstract 3744: Antitumor activity of CUDC-907, a dual PI3K and HDAC inhibitor, in hematological cancer models
2012
·
Bao Rudi
, Dagong Wang
, et al.
·
Cancer Research
·
7
CUDC-907, a Dual HDAC and PI3K Inhibitor, Potentially Targets Cancer Cells and The Microenvironment In Hematological Malignancies
2013
·
Jing Wang
, Natalie Pursell
, et al.
·
Blood
·
3
Abstract 3249: Design and synthesis of imidazopyridine derivatives as novel HSP90 inhibitors for the treatment of cancer
2011
·
Xiong Cai
, Hai-Xiao Zhai
, et al.
·
Cancer Research
·
1
Abstract 2615: Antitumor activity of a dual PI3K and HDAC inhibitor in hematologic cancer models
2011
·
Rudi Bao
, Dagong Wang
, et al.
·
Cancer Research
·
1
Supplementary Figures 1 - 9 from Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2023
·
Changgeng Qian
, Cheng-Jung Lai
, et al.
Data from Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2023
·
Changgeng Qian
, Cheng-Jung Lai
, et al.
Data from Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2023
·
Changgeng Qian
, Cheng-Jung Lai
, et al.
Supplementary Tables 1-4, Figures 1-9 from CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2023
·
Cheng-Jung Lai
, Rudi Bao
, et al.
PDF
Supplementary Tables 1-4, Figures 1-9 from CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2023
·
Cheng-Jung Lai
, Rudi Bao
, et al.
Data from CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2023
·
Cheng-Jung Lai
, Rudi Bao
, et al.
Abstract C70: Antitumor activity of CUDC-907, a single small molecule inhibitor that targets both PI3K and HDAC, in hematologic cancer models.
2011
·
Rudi Bao
, Dagong Wang
, et al.
·
Molecular Cancer Therapeutics
Abstract 2619: Potential advantages of CUDC-101, a multi-targeted HDAC, EGFR and HER2 inhibitor, on preventing drug resistance and tumor metastasis
2011
·
Jing Wang
, Kader Selmi
, et al.
·
Cancer Research
Abstract 4469: Antitumor activity of a single small molecule agent targeting Pi3K/mTor and HDAC
2010
·
Rudi Bao
, Cheng-Jung Lai
, et al.
·
Cancer Research
Show more works
View as search
Works count:
21
Citation count:
1,317
H-index:
8
I10-index:
8
Year
Topic
Type
